Sex-linked differences in the vasorelaxant effects of anandamide in vascular mesenteric beds: Role of oestrogens
Anandamide (0.01 to 10 μM) caused greater concentration-dependent reductions of the contractile-induced responses to noradrenaline in female than in male mesenteric vascular beds isolated from adult Sprague-Dawley rats. Greater relaxant responses in females were also induced by the vanilloid TRPV1 r...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
2004
|
| Materias: | |
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 15193caa a22017057a 4500 | ||
|---|---|---|---|
| 001 | PAPER-21227 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518205240.0 | ||
| 008 | 190411s2004 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-2942552799 | |
| 024 | 7 | |2 cas |a acetylcholine, 51-84-3, 60-31-1, 66-23-9; anandamide, 94421-68-8; capsaicin, 404-86-4; capsazepine, 138977-28-3; cycloheximide, 642-81-9, 66-81-9; estradiol benzoate, 50-50-0; estradiol, 50-28-2; nitroprusside sodium, 14402-89-2, 15078-28-1; noradrenalin, 1407-84-7, 51-41-2; rimonabant, 158681-13-1, 168273-06-1; Acetylcholine, 51-84-3; anandamide, 94421-68-8; Arachidonic Acids; Capsaicin, 404-86-4; capsazepine; Cycloheximide, 66-81-9; estradiol 3-benzoate, 50-50-0; Estradiol, 50-28-2; Estrogens; Nitroprusside, 15078-28-1; Norepinephrine, 51-41-2; Phenylmethylsulfonyl Fluoride, 329-98-6; Piperidines; Polyunsaturated Alkamides; Pyrazoles; SR 141716A, 158681-13-1 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a EJPHA | ||
| 100 | 1 | |a Peroni, R.N. | |
| 245 | 1 | 0 | |a Sex-linked differences in the vasorelaxant effects of anandamide in vascular mesenteric beds: Role of oestrogens |
| 260 | |c 2004 | ||
| 270 | 1 | 0 | |m Adler-Graschinsky, E.; Inst. de Invest. Farmacologicas, Junín 956, 1113 Buenos Aires, Argentina; email: eadler@ffyb.uba.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Andersson, D.A., Adner, M., Högestätt, E.D., Zygmunt, P.M., Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists (2002) Mol. Pharmacol., 62, pp. 705-713 | ||
| 504 | |a Bowyer, L., Brown, M.A., Jones, M., Vascular reactivity in men and women of reproductive age (2001) Am. J. Obstet. Gynecol., 185, pp. 88-96 | ||
| 504 | |a Caterina, M.J., Schumacher, M.A., Tominaga, M., Rosen, T.A., Levine, J.D., Julius, D., The capsaicin receptor: A heat-activated ion channel in the pain pathway (1997) Nature, 389, pp. 816-824 | ||
| 504 | |a Caulin-Glaser, T., Garcia-Cardena, G., Sarrel, P., Sessa, W.C., Bender, J.R., 17 Beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization (1997) Circ. Res., 81, pp. 885-892 | ||
| 504 | |a De Petrocellis, L., Bisogno, T., MacCarrone, M., Davis, J.B., Finazzi-Agro, A., Di Marzo, V., The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism (2001) J. Biol. Chem., 276, pp. 12856-12863 | ||
| 504 | |a De Petrocellis, L., Harrison, S., Bisogno, T., Tognetto, M., Brandi, I., Smith, G.D., Creminon, C., Di Marzo, V., The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase (2001) J. Neurochem., 77, pp. 1660-1663 | ||
| 504 | |a Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mechoulam, R., Isolation and structure of a brain constituent that binds to the cannabinoid receptor (1992) Science, 258, pp. 1946-1949 | ||
| 504 | |a Doolan, C.M., Condliffe, S.B., Harvey, B.J., Rapid non-genomic activation of citosolic cyclic AMP-dependent protein kinase activity and [Ca2+]I by 17β-oestradiol in female rat distal colon (2000) Br. J. Pharmacol., 129, pp. 1375-1386 | ||
| 504 | |a Fulton, C.T., Stallone, J.N., Sexual dimorphism in prostanoid-potentiated vascular contraction: Roles of endothelium and ovarian steroids (2002) Am. J. Physiol. Heart Circ. Physiol., 283, pp. 2062-H2073 | ||
| 504 | |a Gangula, P.R.R., Zhao, H., Supowit, S., Wimalawansa, S., Dipette, D., Yallampalli, C., Pregnancy and steroid hormones enhances the vasodilation responses to CGRP in rats (1999) Am. J. Physiol. Heart Circ. Physiol., 276, pp. 284-H288 | ||
| 504 | |a Gilligan, D.M., Badar, D.M., Panza, J.A., Quyyumi, A.A., Cannon III, R.O., Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women (1995) Am. J. Cardiol., 75, pp. 264-268 | ||
| 504 | |a Gooren, L.J., Toorians, A.W., Significance of oestrogens in male (patho)physiology (2003) Ann. Endocrinol. (Paris), 64, pp. 126-135 | ||
| 504 | |a Grewal, M., Cuevas, J., Chaudhuri, G., Nathan, L., Effects of calcitonin gene-related peptide on vascular resistance in rats: Role of sex steroids (1999) Am. J. Physiol., 276, pp. 2063-H2068 | ||
| 504 | |a Holzer, P., Capsaicin: Cellular targets, mechanisms of action and selectivity for thin sensory neurons (1991) Pharmacol. Rev., 43, pp. 143-201 | ||
| 504 | |a Howlett, A.C., The cannabinoids receptors (2002) Prostaglandins Other Lipid Mediat., 6869, pp. 619-631 | ||
| 504 | |a Koreman, S.G., Stevens, R.H., Carpenter, L.A., Robe, M., Niswender, G.D., Sherman, B.M., Estradiol radioimmunoassay without chromatography: Procedure, validation and normal values (1974) J. Clin. Endocrinol. Metab., 38, pp. 718-720 | ||
| 504 | |a MacCarrone, M., Bari, M., Battista, N., Finazzi-Agro, A., Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation (2002) Blood, 100, pp. 4040-4048 | ||
| 504 | |a Magness, R.R., Rosenfeld, C.R., Local and systemic estradiol-17 beta: Effects on uterine and systemic vasodilation (1989) Am. J. Physiol., 256, pp. 536-E542 | ||
| 504 | |a Marino, M., Distefano, E., Trentalance, A., Smith, C.L., Estradiol-induced IP(3) mediates the estrogen receptor activity expressed in human cells (2001) Mol. Cell Endocrinol., 182, pp. 19-26 | ||
| 504 | |a McCulloch, A.I., Randall, M.D., Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed (1998) Br. J. Pharmacol., 123, pp. 1700-1706 | ||
| 504 | |a McGregor, D.D., The effects of sympathetic nerve stimulation on vasoconstrictor response in perfused mesenteric blood vessels of the rat (1965) J. Physiol., 177, pp. 21-30 | ||
| 504 | |a Mendizábal, V.E., Feleder, E.C., Adler-Graschinsky, E., Effects of chronic in vivo administration of L-NAME on the contractile responses of the rat perfused mesenteric bed (1999) J. Auton. Pharmacol., 19, pp. 241-248 | ||
| 504 | |a Mendizábal, V.E., Orliac, M.L., Adler-Graschinsky, E., Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed (2001) Eur. J. Pharmacol., 427, pp. 251-262 | ||
| 504 | |a Miller, V.M., Barber, D.A., Fenton, A.M., Wang, X., Sieck, G.C., Gender differences in response to endothelin-1 in coronary arteries: Transcription, receptors and calcium regulation (1996) Clin. Exp. Pharmacol. Physiol., 23, pp. 256-259 | ||
| 504 | |a Nickenig, G., Strehlow, K., Wassmann, S., Baumer, A.T., Albory, K., Sauer, H., Bohm, M., Differential effects of estrogen and progesterone on AT(1) receptor gene expression in vascular smooth muscle cells (2000) Circulation, 102, pp. 1828-1833 | ||
| 504 | |a Norfleet, A.M., Clarke, C.H., Gametchu, B., Watson, C.S., Antibodies to the estrogen receptor-alpha modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors (2000) FASEB J., 1, pp. 157-165 | ||
| 504 | |a Orliac, M.L., Peroni, R., Celuch, S.M., Adler-Graschinsky, E., Potentiation of anandamide effects in mesenteric beds isolated from endotoxemic rats (2003) J. Pharmacol. Exp. Ther., 304, pp. 179-184 | ||
| 504 | |a Premkumar, L.S., Ahern, G.P., Induction of vanilloid receptor channel activity by protein kinase C (2000) Nature, 408, pp. 985-990 | ||
| 504 | |a Pugeat, M., Moulin, P., Cousin, P., Fimbel, S., Nicolas, M.H., Crave, J.C., Lejeune, H., Interrelations between sex hormone-binding globulin (SHBG), plasma lipoproteins and cardiovascular risk (1995) J. Steroid. Biochem. Mol. Biol., 53, pp. 567-572 | ||
| 504 | |a Razandi, M., Pedram, A., Greene, G.L., Levin, E.R., Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells (1999) Mol. Endocrinol., 2, pp. 307-319 | ||
| 504 | |a Stampfer, M.J., Colditz, G.A., Willett, W.C., Manson, J.E., Rosner, B., Speizer, F.E., Hennekens, C.H., Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study (1991) N. Engl. J. Med., 325, pp. 756-762 | ||
| 504 | |a Takeda-Matsubara, Y., Nakagami, H., Iwai, M., Cui, T.X., Shiuchi, T., Akishita, M., Nahmias, C., Horiuchi, M., Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II (2002) Hypertension, 39, pp. 41-45 | ||
| 504 | |a Tan, Z., Wang, T.H., Yang, D., Fu, X.D., Pan, J.Y., Mechanisms of 17beta-estradiol on the production of ET-1 in ovariectomized rats (2003) Life Sci., 73, pp. 2665-2674 | ||
| 504 | |a Tep-Areenan, P., Kendall, D.A., Randall, M.D., Mechanisms of vasorelaxation to 17beta-oestradiol in rat arteries (2003) Eur. J. Pharmacol., 476, pp. 139-149 | ||
| 504 | |a Tolbert, T., Oparil, S., Cardiovascular effects of estrogen (2001) Am. J. Hypertens., 6, pp. 186S-193S | ||
| 504 | |a Tostes, R.C., Nigro, D., Fortes, Z.B., Carvalho, M.H.E., Effects of estrogen on the vascular system (2003) Braz. J. Med. Biol. Res., 36, pp. 1143-1158 | ||
| 504 | |a Vanheel, B., Van De Voorde, J., Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries (2001) J. Pharmacol. Exp. Ther., 296, pp. 322-328 | ||
| 504 | |a Zygmunt, P.M., Petersson, J., Andersson, D.A., Chuang, H., Sorgard, M., Di Marzo, V., Julius, D., Högestätt, E.D., Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide (1999) Nature, 400, pp. 452-457 | ||
| 520 | 3 | |a Anandamide (0.01 to 10 μM) caused greater concentration-dependent reductions of the contractile-induced responses to noradrenaline in female than in male mesenteric vascular beds isolated from adult Sprague-Dawley rats. Greater relaxant responses in females were also induced by the vanilloid TRPV1 receptor agonist capsaicin (0.01 to 10 μM), whereas no sex differences were observed for the relaxations caused by either acetylcholine or sodium nitroprusside. The effect of anandamide in either sex was reduced by the vanilloid TRPV1 receptor antagonist capsazepine but not by the cannabinoid CB1 receptor antagonist N-piperidino-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-3-pyrazole-carboxamide (SR141716A). In males, the anandamide-induced relaxations were potentiated by in vitro exposure during 5 min to 0.5 μM 17β-oestradiol and unmodified by the protein synthesis inhibitor cycloheximide. The vasorelaxant effects of anandamide in female rats were decreased by ovariectomy. This decrease was prevented by in vivo treatment with 17β-oestradiol-3-benzoate (450 μg/kg i.m., once a week during 3 weeks) and counteracted by in vitro exposure to oestrogen. In vivo treatment with 17β-oestradiol also potentiated anandamide-induced responses in males. In conclusion, this study shows an oestrogen-dependent sensitivity to the vanilloid TRPV1 receptor-mediated vasorelaxant effects of anandamide in the mesenteric vasculature of Sprague-Dawley rats, that could be mediated by both genomic and non-genomic mechanisms. © 2004 Elsevier B.V. All rights reserved. |l eng | |
| 536 | |a Detalles de la financiación: Fundación Antorchas | ||
| 536 | |a Detalles de la financiación: Agencia Nacional de Promoción Científica y Tecnológica, 14156-3, 14022-112 | ||
| 536 | |a Detalles de la financiación: The technical assistance of Ms Fernanda De Fino and Ms Marina Galli is gratefully acknowledged. This work was supported by grants PICT 99/05-06917 from Agencia Nacional de Promoción Cientı́fica y Tecnológica and Research Projects 14022-112 and 14156-3 from Fundación Antorchas. | ||
| 593 | |a Inst. de Invest. Farmacologicas, Junín 956, 1113 Buenos Aires, Argentina | ||
| 593 | |a Inst. de Biol. Y Med. Experimental, Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina | ||
| 593 | |a U. de Regulación Neurohumoral, Depto. de Cie. Fisiológicas, Pont. Univ. Católica de Chile, Santiago de Chile, Chile | ||
| 690 | 1 | 0 | |a (SPRAGUE-DAWLEY RAT) |
| 690 | 1 | 0 | |a 17Β-OESTRADIOL |
| 690 | 1 | 0 | |a ANANDAMIDE |
| 690 | 1 | 0 | |a SEX DIFFERENCE |
| 690 | 1 | 0 | |a VASORELAXATION |
| 690 | 1 | 0 | |a ACETYLCHOLINE |
| 690 | 1 | 0 | |a ANANDAMIDE |
| 690 | 1 | 0 | |a CANNABINOID 1 RECEPTOR |
| 690 | 1 | 0 | |a CANNABINOID RECEPTOR ANTAGONIST |
| 690 | 1 | 0 | |a CAPSAICIN |
| 690 | 1 | 0 | |a CAPSAZEPINE |
| 690 | 1 | 0 | |a CYCLOHEXIMIDE |
| 690 | 1 | 0 | |a ESTRADIOL |
| 690 | 1 | 0 | |a ESTRADIOL BENZOATE |
| 690 | 1 | 0 | |a ESTROGEN |
| 690 | 1 | 0 | |a NITROPRUSSIDE SODIUM |
| 690 | 1 | 0 | |a NORADRENALIN |
| 690 | 1 | 0 | |a PROTEIN SYNTHESIS INHIBITOR |
| 690 | 1 | 0 | |a RIMONABANT |
| 690 | 1 | 0 | |a VANILLOID RECEPTOR |
| 690 | 1 | 0 | |a ANIMAL EXPERIMENT |
| 690 | 1 | 0 | |a ANIMAL TISSUE |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a BLOOD VESSEL |
| 690 | 1 | 0 | |a CONCENTRATION RESPONSE |
| 690 | 1 | 0 | |a CONTROLLED STUDY |
| 690 | 1 | 0 | |a DOSE RESPONSE |
| 690 | 1 | 0 | |a DRUG EFFECT |
| 690 | 1 | 0 | |a ESTROGEN ACTIVITY |
| 690 | 1 | 0 | |a EXPOSURE |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a IN VITRO STUDY |
| 690 | 1 | 0 | |a ISOLATED ORGAN |
| 690 | 1 | 0 | |a MALE |
| 690 | 1 | 0 | |a MUSCLE CONTRACTILITY |
| 690 | 1 | 0 | |a NONHUMAN |
| 690 | 1 | 0 | |a OVARIECTOMY |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a RAT |
| 690 | 1 | 0 | |a SEX DIFFERENCE |
| 690 | 1 | 0 | |a VASODILATATION |
| 690 | 1 | 0 | |a ACETYLCHOLINE |
| 690 | 1 | 0 | |a ANIMALS |
| 690 | 1 | 0 | |a ARACHIDONIC ACIDS |
| 690 | 1 | 0 | |a CAPSAICIN |
| 690 | 1 | 0 | |a CYCLOHEXIMIDE |
| 690 | 1 | 0 | |a DOSE-RESPONSE RELATIONSHIP, DRUG |
| 690 | 1 | 0 | |a DRUG SYNERGISM |
| 690 | 1 | 0 | |a ESTRADIOL |
| 690 | 1 | 0 | |a ESTROGENS |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a MALE |
| 690 | 1 | 0 | |a MESENTERY |
| 690 | 1 | 0 | |a MUSCLE, SMOOTH, VASCULAR |
| 690 | 1 | 0 | |a NITROPRUSSIDE |
| 690 | 1 | 0 | |a NOREPINEPHRINE |
| 690 | 1 | 0 | |a OVARIECTOMY |
| 690 | 1 | 0 | |a PHENYLMETHYLSULFONYL FLUORIDE |
| 690 | 1 | 0 | |a PIPERIDINES |
| 690 | 1 | 0 | |a POLYUNSATURATED ALKAMIDES |
| 690 | 1 | 0 | |a PYRAZOLES |
| 690 | 1 | 0 | |a RATS |
| 690 | 1 | 0 | |a RATS, SPRAGUE-DAWLEY |
| 690 | 1 | 0 | |a SEX CHARACTERISTICS |
| 690 | 1 | 0 | |a TIME FACTORS |
| 690 | 1 | 0 | |a VASODILATION |
| 651 | 4 | |a ARGENTINA | |
| 651 | 4 | |a CHILE | |
| 653 | 0 | 0 | |a sr 141716a, Labaz, France |
| 700 | 1 | |a Orliac, M.L. | |
| 700 | 1 | |a Becu-Villalobos, D. | |
| 700 | 1 | |a Huidobro-Toro, J.P. | |
| 700 | 1 | |a Adler-Graschinsky, E. | |
| 700 | 1 | |a Celuch, S.M. | |
| 773 | 0 | |d 2004 |g v. 493 |h pp. 151-160 |k n. 1-3 |p Eur. J. Pharmacol. |x 00142999 |w (AR-BaUEN)CENRE-1772 |t European Journal of Pharmacology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-2942552799&doi=10.1016%2fj.ejphar.2004.04.031&partnerID=40&md5=d3ec19a805073584ecfbdebd39580a83 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejphar.2004.04.031 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_00142999_v493_n1-3_p151_Peroni |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00142999_v493_n1-3_p151_Peroni |y Registro en la Biblioteca Digital |
| 961 | |a paper_00142999_v493_n1-3_p151_Peroni |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 82180 | ||